Concentrated cell-free supernatants were mixed with normal (healthy) human pooled plasma samples (George King) for 20 min at 37°C. An equal volume of aPTT reagent (Pacific Hemostasis) was added. After incubation for 5 min, CaCl2 (final 10 mM) was added. Clot times were determined using an Amelung KC4A Micro Coagulation analyzer.
To identify the target of CpaA, a modified aPTT assay was performed by first incubating concentrated AB031 supernatant with normal plasma. After incubation, the plasma was diluted 1:100 and added to human plasma samples derived from donors deficient in congenital coagulation factor (George King), and an aPTT assay was performed as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.